Immuneering Corporation (IMRX)
undefined
undefined%
At close: undefined
1.60
-2.44%
After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - 316.95K 2.08M 2.31M 1.92M
Cost of Revenue 764.14K 158.12K 1.15M 1.28M 1.22M
Gross Profit -764.14K 158.83K 926.89K 1.03M 696.74K
Operating Income -58.41M -51.74M -33.89M -17.08M -6.29M
Interest Income 3.61M 1.01M 169.90K 42.66K 57.66K
Pretax Income -53.47M -50.51M -33.84M -17.04M -7.71M
Net Income -53.47M -49.28M -33.54M -17.04M -8.06M
Selling & General & Admin 16.76M 15.61M 8.27M 3.11M 2.71M
Research & Development 41.40M 36.27M 26.54M 15.00M 4.28M
Other Expenses - 30.05K -127.06K - -
Operating Expenses 58.41M 51.90M 34.81M 18.11M 6.99M
Interest Expense - 1.01M - - 351.30K
Selling & Marketing Expenses - - - - -
Cost & Expenses 58.41M 52.06M 35.97M 19.39M 8.21M
Income Tax - -1.23M -307.49K -84.34K 351.30K
Shares Outstanding (Basic) 28.42M 26.39M 26.32M 25.51M 25.51M
Shares Outstanding (Diluted) 28.42M 26.39M 26.32M 25.51M 25.51M
EPS (Basic) -1.88 -1.87 -1.27 -0.67 -0.32
EPS (Diluted) -1.88 -1.87 -1.27 -0.67 -0.32
EBITDA -58.06M -51.47M -33.68M -17.00M -7.34M
Depreciation & Amortization 352.08K 796.79K 159.07K 79.31K 18.08K